Search

Search Constraints

You searched for: Author/Creator Sultan, Keith

Search Results

1. Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease. Issue 11 (18th May 2018)

6. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. (January 2022)

10. Real World Usage Patterns of Vedolizumab in Inflammatory Bowel Disease: Results From the VICTORY Consortium: 2017 Presidential Poster Award: 726. (October 2017)